Perceived need of,and interest in,HIV pre-exposure prophylaxis amongst men who have sex with men attending three sexual health clinics in London,UK

Abstract

HIV pre-exposure prophylaxis (PrEP) has proven efficacy in reducing the risk of HIV infection in men who have sex with men (MSM), but has not yet been commissioned in the UK. The aim of this study was to investigate perceived need and benefit (or experience of) PrEP among HIV-negative MSM attending sexual health clinics. HIV-negative MSM attending three sexual health centres in London, UK were opportunistically invited to complete a questionnaire. Data collected comprised demographic data and sexual and drug use behaviours as well as questions regarding perceptions of risk and need for PrEP. Logistic regression analysis was undertaken to identify variables predicting acceptability of, and intention to use, PrEP. In addition, data were gathered in respondents already taking PrEP. Eight hundred and thirty-nine questionnaires were analysed. The median age of respondents was 35 years (IQR 28–41, range 18–78), 650 (77%) were of white ethnicity and 649 (77%) had a university education. Four hundred and fifty-six (54%) reported at least one episode of condomless anal sex in the preceding three months, 437 (52%) reported recreational drug use in the preceding three months and 311 (37%) had been diagnosed with a sexually transmitted infection within the preceding six months. Four hundred and sixty-three (64%) of 726 strongly agreed with the statement ‘I think I would benefit from PrEP’. Multivariate logistic regression analysis demonstrated that having receptive anal intercourse (RAI) without condoms, having an awareness of the risk of unprotected RAI and having belief in the effectiveness of PrEP were independent predictors for someone thinking they would benefit from taking PrEP. Eight percent of respondents (59/724) had already taken or were currently taking PrEP. The results suggest that individuals at risk are likely to perceive themselves as benefiting from PrEP. The majority perceived their risk of acquiring HIV and benefit from PrEP accurately. Overall they appeared to have little concern over the use of PrEP and generally positive attitudes. Further investigation is warranted to understand why those at risk do not perceive benefit from PrEP.

Keywords

High-risk behaviour homosexual sexual behaviour human immunodeficiency virus viral disease prevention pre-exposure prophylaxis

Get full access to this article

View all access options for this article.

References

Grant

Lama

Anderson

et al.

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

N Engl J Med 2010; 363: 2587–2599.

Baeten

Donnell

Ndase

et al.

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

N Engl J Med 2012; 367: 399–410.

Thigpen

Kebaabetswe

Paxton

et al.

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

N Engl J Med 2012; 367: 423–434.

Holmes

FDA paves the way for pre-exposure HIV prophylaxis.

Lancet 2012; 380: 325.

McCormack

Dunn

Desai

et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 2016; 387: 53–60.

Molina

Capitant

Spire

et al.

On-demand preexposure prophylaxis in men at high risk for HIV-1 infection.

N Engl J Med 2015 ;373: 2237–2246.

Public Health England. HIV in the United Kingdom: Situation Report 2015, Incidence, prevalence and prevention. London: PHE, 2015.

Wilson

DP.

HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention.

PLoS Med 2012; 9: e1001231.

Brown

Nardone

and Delpech

VC.

WHO ‘treatment as prevention’ guidelines are unlikely to decrease HIV transmission in the UK unless undiagnosed HIV infections are reduced.

AIDS 2014; 28: 281–283.

10.

Delpech

and Desai

On behalf of the HIV & STI team at Colindale Public Health England. Towards elimination of HIV amongst gay and bisexual men in the United Kingdom, http://www.bhiva.org/documents/Conferences/2017Liverpool/Presentations/170405/ValerieDelpech-MonicaDesai.pdf (accessed March 2017).

11.

Cambiano

Miners

Dunn

et al.

Is pre-exposure prophylaxis for HIV prevention cost-effective in men who have sex with men who engage in condomless sex in the UK?

Sex Transm Infect 2015; 91(Suppl. 1): A1.

12.

Gomez

Borquez

Case

et al.

The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies.

PLoS Med 2013; 10: e1001401.

13.

Young

and McDaid

How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention.

AIDS Behav 2014; 18: 195–216.

14.

Cohen

Vittinghoff

Bacon

et al.

High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project. J Acquir Immune Deﬁc Syndr 2015; 68: 439–448.

15.

Genitourinary medicine clinical activity dataset (V2). PHE 2015.

16.

Desai

Nardone

Hughes

et al. HIV incidence in an open national cohort of men who have sex with men attending sexually transmitted infection clinics in England. HIV Med. Epub ahead of print 27 January 2017. DOI: 10.1111/hiv.12498.

17.

Dolling

Desai

McOwan

et al. An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis. Trials 2016; 17: 163.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.69 MB